In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008.
Patel
Samir N
SN
Pillai
Dylan R
DR
Pong-Porter
Sylvia
S
McGeer
Allison
A
Green
Karen
K
Low
Donald E
DE
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002170:Canada; D002511:Cephalosporins / Q000494:pharmacology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D048628:Ketolides / Q000494:pharmacology*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D013290:Streptococcal Infections / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification; D055815:Young Adult; D000097583:Ceftaroline
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D048628:Ketolides; D000097583:Ceftaroline; C443755:ceftobiprole; C405499:cethromycin